These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7945625)

  • 21. The controversy surrounding indomethacin for tocolysis.
    Macones GA; Marder SJ; Clothier B; Stamilio DM
    Am J Obstet Gynecol; 2001 Feb; 184(3):264-72. PubMed ID: 11228471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The safety of prolonged indomethacin therapy.
    Savage AH; Anderson BL; Simhan HN
    Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor.
    Bivins HA; Newman RB; Fyfe DA; Campbell BA; Stramm SL
    Am J Obstet Gynecol; 1993 Oct; 169(4):1065-70. PubMed ID: 8238121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized intestinal perforations after enteral administration of indomethacin in premature infants.
    Alpan G; Eyal F; Vinograd I; Udassin R; Amir G; Mogle P; Glick B
    J Pediatr; 1985 Feb; 106(2):277-81. PubMed ID: 3968618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ductus-dependent fetal cardiac defects contraindicate indomethacin tocolysis.
    Saenger JS; Mayer DC; D'Angelo LJ; Manci EA
    J Perinatol; 1992 Mar; 12(1):41-7. PubMed ID: 1560290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats.
    Toyoshima K; Momma K; Nakanishi T
    Neonatology; 2009; 96(2):125-31. PubMed ID: 19279396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal versus oral indomethacin in a rabbit model for non-infection-mediated preterm birth: an alternate tocolytic approach.
    Fortson W; Beharry KD; Nageotte S; Sills JH; Stavitsky Y; Asrat T; Modanlou HD
    Am J Obstet Gynecol; 2006 Oct; 195(4):1058-64. PubMed ID: 17000239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.
    Ben-David Y; Hallak M; Rotschild A; Sorokin Y; Auslender R; Abramovici H
    Fetal Diagn Ther; 1996; 11(5):341-4. PubMed ID: 8894629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preterm delivery after indomethacin. A risk factor for neonatal complications?
    Gardner MO; Owen J; Skelly S; Hauth JC
    J Reprod Med; 1996 Dec; 41(12):903-6. PubMed ID: 8979204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal intestinal ischemia with bowel perforation: an in utero complication of maternal cocaine abuse.
    Hall TR; Zaninović A; Lewin D; Barrett C; Boechat MI
    AJR Am J Roentgenol; 1992 Jun; 158(6):1303-4. PubMed ID: 1590129
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous indomethacin therapy.
    Crawshaw A
    J Paediatr Child Health; 1992 Apr; 28(2):198. PubMed ID: 1562379
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age.
    Vermillion ST; Scardo JA; Lashus AG; Wiles HB
    Am J Obstet Gynecol; 1997 Aug; 177(2):256-9; discussion 259-61. PubMed ID: 9290437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.
    Wurtzel D
    Obstet Gynecol; 1990 Oct; 76(4):689-92. PubMed ID: 2216206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of long-term tocolysis with indomethacin.
    Gerson A; Abbasi S; Johnson A; Kalchbrenner M; Ashmead G; Bolognese R
    Am J Perinatol; 1990 Jan; 7(1):71-4. PubMed ID: 2294913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.
    Shen O; Rabinowitz R; Lavie O; Aboulafia Y; Diamant YZ
    J Perinat Med; 1995; 23(3):233-6. PubMed ID: 8568616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent ductus arteriosus after prolonged treatment with indomethacin during pregnancy: case report.
    Atad J; Lissak A; Rofe A; Abramovici H
    Int J Gynaecol Obstet; 1987 Feb; 25(1):73-6. PubMed ID: 2883050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal and neonatal effects of indomethacin used as a tocolytic agent.
    Dudley DK; Hardie MJ
    Am J Obstet Gynecol; 1985 Jan; 151(2):181-4. PubMed ID: 3970083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem.
    Altshuler G; Krous HF; Altmiller DH; Sharpe GL
    Am J Obstet Gynecol; 1979 Sep; 135(2):261-5. PubMed ID: 112867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.